TABLE 2.

Clinical presentation and outcomes of COVID‐19 infection

		N = 87
Clinical presentation, n (%)
	Asymptomatic	26 (30)
	Fever	38 (44)
	Myalgia	16 (18)
	URI	47 (54)
	LRI	18 (21)
	GI	25 (29)
	Neurological	9 (10)
	Cardiac	5 (6)
	Skin	6 (7)
Hospitalization, n (%)
	COVID related	26 (30)
	Multiple hospitalizations	4
	COVID unrelated	14 (16)
	Not hospitalized	47 (54)
Severity a
	Mild	69
	Moderate	10
	Severe	2
	Critical	6
Hypoxia, n (%)		12 (14)
Intensive care, n (%)		6 (7)
	Invasive ventilation b	2
	Organ failure	6
Any treatment, n (%)		19 (22)
	Remdesivir	14
	Steroids	11
	Monoclonal	2
	Convalescent Plasma	4
	Hydroxychloroquine	1
	Azithromycin	2
	Other	1
Therapy delay (n = 64 on active therapy)
	Delayed	22
Duration of delay (days, median (range))		14 (2‐39) c

Abbreviations: LRI, lower respiratory infection; URI, upper respiratory infection.

^a Severity was graded using the World Health Organization scale. Mild: no pneumonia or hypoxia. Moderate: clinical signs of pneumonia, chest radiography may help in diagnosis. Severe: oxygen saturation <90% on room air or signs of severe respiratory distress (accessory muscle use, grunting.) Critical: life‐sustaining treatment for conditions such as acute respiratory distress syndrome (ARDS), sepsis, or septic shock.

^b Intubation and ventilation.

^c Radiotherapy was omitted in one patient due to COVID‐19.